Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 161-180
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 William Cohn Professor of Surgery at Baylor College of Medicine (Immunology, Allergy & Rheumatology) | Bellaire, United States | Corporate VCVenture capital | AIHealthcare | ||
 Charles McIntyre Co-Founder at Ibis Capital | London, United Kingdom | Private equityVenture capital | ConsumerEducation | ||
 James Flynn Managing Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 David Berger Partner at Wilson Sonsini Goodrich & Rosati | Palo Alto, United States | Corporate VC | AIClimate | ||
 Phillip Samayoa Venture Partner at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | ||
 Sai Abhishek Vice President at Enavate Sciences | New York, United States | Venture capital | Healthcare | ||
 Gary Bornstein Program Manager at Point72 | New York City, United States | Private equityVenture debt | AIClimate | ||
 Matthew J. Hobson Principal at Catalio Capital Management | New York, United States | Venture capitalVenture debt | AIHealthcare | ||
 Hui Cheng Principal, Digital Health at New Enterprise Associates (NEA) | San Francisco, United States | Venture capital | AICommerce | ||
 David Siet Principal at Amzak Health Investors | New York, United States | Private equityVenture capital | Healthcare | ||
 Cris De Luca Partner, AI and Digital Investments at Sanofi | Cambridge, United States | Corporate VC | AIHealthcare | ||
 Peter Steelman Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 Michael Widmann Associate Director, Portfolio Strategy & Analytics at AbbVie | Chicago, United States | Corporate VC | Healthcare | ||
 Rich Levandov Partner at Avalon Partners | Belmont, United States | Venture capital | AIConsumer | ||
 Philip Chopin Managing Director, NEA UK at New Enterprise Associates (NEA) | London, United Kingdom | Venture capital | AICommerce | ||
 Jeffrey Haithcock Medical Advisory Board Member at VIC Tech | Dallas, United States | AcceleratorVenture capital | HealthcareSaaS | ||
 Marianne Mertens Investment Committee Member at Alzheimer's Drug Discovery Foundation | Munich, Germany | Venture capital | Healthcare | ||
 Dustin Robinson Founder at Iter Investments | Miami Beach, United States | Venture capital | AIClimate | ||
 Alda Leu Dennis Managing Partner at Hawktail | San Francisco, United States | Venture capital | AICommerce | ||
 Rianne Ellenbroek Principal at Bgv (biogeneration Ventures) | Amsterdam, Netherlands | Venture capital | Healthcare |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal